Suchergebnisse
Filter
11 Ergebnisse
Sortierung:
Women rising in resistance A direct action network
In: Women's studies international forum, Band 12, Heft 1, S. 113-118
Civilizing Peace Building: Twenty-first Century Global Politics
Highlighting the high price paid by the United Nations and international peace builders that under-utilize the reflexive new paradigm approach to international relations (IR), this study develops an overview of IR theory, relied on by governmental and diplomatic communities as a guide to peace building.
Friendship versus Faith: How Latter-day Saint College Students Manage the Conflicts between Their Beliefs about Homosexuality and Their Friendships with Gay and Lesbian Persons
In: The sociological quarterly: TSQ, Band 62, Heft 2, S. 305-322
ISSN: 1533-8525
NARRATIVE EMPATHY: A Narrative Policy Framework Study of Working-Class Climate Change Narratives and Narrators
In: World affairs: a journal of ideas and debate, Band 185, Heft 3, S. 471-499
ISSN: 1940-1582
Understanding the reasoning behind diverse views grows empathy and can help strengthen democracy. This study examines narratives and their influence on individuals, to see if individuals only empathize with narratives from those with whom they share identity. Using an experimental design, we test empathy with working class climate change narratives. Results showed participants who agreed with anthropogenic climate change, who were given both evidence and a narrative, empathized with the narrator (either an organic farmer or a mechanic) that told a pro-climate change narrative. The greatest empathy was for the mechanic telling a pro-climate change narrative. Conversely, participants who did not agree with human-caused climate change and who were given evidence without narrative had more empathy for the organic farmer (over the mechanic) who told a pro-climate change narrative. Overall, we found some identity issues negatively influenced empathy, but we also found examples where individuals moved beyond their identity.
Physical properties of z>4 submillimeter galaxies in the COSMOS field
We study the physical properties of a sample of 6 SMGs in the COSMOS field, spectroscopically confirmed to lie at z>4. We use new GMRT 325 MHz and 3 GHz JVLA data to probe the rest-frame 1.4 GHz emission at z=4, and to estimate the sizes of the star-forming (SF) regions of these sources, resp. Combining our size estimates with those available in the literature for AzTEC1 and AzTEC3 we infer a median radio-emitting size for our z>4 SMGs of (0.63"+/-0.12")x(0.35"+/-0.05") or 4.1x2.3 kpc^2 (major times minor axis; assuming z=4.5) or lower if we take the two marginally resolved SMGs as unresolved. This is consistent with the sizes of SF regions in lower-redshift SMGs, and local normal galaxies, yet higher than the sizes of SF regions of local ULIRGs. Our SMG sample consists of a fair mix of compact and more clumpy systems with multiple, perhaps merging, components. With an average formation time of ~280 Myr, derived through modeling of the UV-IR SEDs, the studied SMGs are young systems. The average stellar mass, dust temperature, and IR luminosity we derive are M*~1.4x10^11 M_sun, T_dust~43 K, and L_IR~1.3x10^13L_sun, resp. The average L_IR is up to an order of magnitude higher than for SMGs at lower redshifts. Our SMGs follow the correlation between dust temperature and IR luminosity as derived for Herschel-selected 0.1=1.95+/-0.26 for our sample, compared to q~2.6 for IR luminous galaxies at z4 SMGs put them at the high end of the L_IR-T_dust distribution of SMGs, and that our SMGs form a morphologically heterogeneous sample. Thus, further in-depth analyses of large, statistical samples of high-redshift SMGs are needed to fully understand their role in galaxy formation and evolution. ; This research was funded by the European Union's Seventh Framework program under grant agreement 337595 (ERC Starting Grant, "CoSMass"). A.K. acknowledges support by the Collaborative Research Council 956, subproject A1, funded by the Deutsche Forschungsgemeinschaft (DFG). The Dark Cosmology Centre is funded by the Danish National Research Foundation.
BASE
Physical properties of z>4 submillimeter galaxies in the COSMOS field
We study the physical properties of a sample of 6 SMGs in the COSMOS field, spectroscopically confirmed to lie at z>4. We use new GMRT 325 MHz and 3 GHz JVLA data to probe the rest-frame 1.4 GHz emission at z=4, and to estimate the sizes of the star-forming (SF) regions of these sources, resp. Combining our size estimates with those available in the literature for AzTEC1 and AzTEC3 we infer a median radio-emitting size for our z>4 SMGs of (0.63"+/-0.12")x(0.35"+/-0.05") or 4.1x2.3 kpc^2 (major times minor axis; assuming z=4.5) or lower if we take the two marginally resolved SMGs as unresolved. This is consistent with the sizes of SF regions in lower-redshift SMGs, and local normal galaxies, yet higher than the sizes of SF regions of local ULIRGs. Our SMG sample consists of a fair mix of compact and more clumpy systems with multiple, perhaps merging, components. With an average formation time of ~280 Myr, derived through modeling of the UV-IR SEDs, the studied SMGs are young systems. The average stellar mass, dust temperature, and IR luminosity we derive are M*~1.4x10^11 M_sun, T_dust~43 K, and L_IR~1.3x10^13L_sun, resp. The average L_IR is up to an order of magnitude higher than for SMGs at lower redshifts. Our SMGs follow the correlation between dust temperature and IR luminosity as derived for Herschel-selected 0.1=1.95+/-0.26 for our sample, compared to q~2.6 for IR luminous galaxies at z4 SMGs put them at the high end of the L_IR-T_dust distribution of SMGs, and that our SMGs form a morphologically heterogeneous sample. Thus, further in-depth analyses of large, statistical samples of high-redshift SMGs are needed to fully understand their role in galaxy formation and evolution. ; This research was funded by the European Union's Seventh Framework program under grant agreement 337595 (ERC Starting Grant, "CoSMass"). A.K. acknowledges support by the Collaborative Research Council 956, subproject A1, funded by the Deutsche Forschungsgemeinschaft (DFG). The Dark Cosmology Centre is funded by the Danish National Research Foundation.
BASE
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
Background: Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods: This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings: Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16-30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77-0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50-0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80-0·88; p<0·001), and full lockdowns (0·57, 0·54-0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11 827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation: Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long-term investment in surge capacity for acute care during public health emergencies to protect elective staff and services.
BASE
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
Background Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16–30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77–0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50–0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80–0·88; p<0·001), and full lockdowns (0·57, 0·54–0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11 827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long-term investment in surge capacity for acute care during public health emergencies to protect elective staff and services. Funding National Institute for Health Research Global Health Research Unit, Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.
BASE
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
Background Surgery is the main modality of cure for solid cancers and was prioritised to continue during COVID-19 outbreaks. This study aimed to identify immediate areas for system strengthening by comparing the delivery of elective cancer surgery during the COVID-19 pandemic in periods of lockdown versus light restriction. Methods This international, prospective, cohort study enrolled 20 006 adult (≥18 years) patients from 466 hospitals in 61 countries with 15 cancer types, who had a decision for curative surgery during the COVID-19 pandemic and were followed up until the point of surgery or cessation of follow-up (Aug 31, 2020). Average national Oxford COVID-19 Stringency Index scores were calculated to define the government response to COVID-19 for each patient for the period they awaited surgery, and classified into light restrictions (index 60). The primary outcome was the non-operation rate (defined as the proportion of patients who did not undergo planned surgery). Cox proportional-hazards regression models were used to explore the associations between lockdowns and non-operation. Intervals from diagnosis to surgery were compared across COVID-19 government response index groups. This study was registered at ClinicalTrials.gov, NCT04384926. Findings Of eligible patients awaiting surgery, 2003 (10·0%) of 20 006 did not receive surgery after a median follow-up of 23 weeks (IQR 16–30), all of whom had a COVID-19-related reason given for non-operation. Light restrictions were associated with a 0·6% non-operation rate (26 of 4521), moderate lockdowns with a 5·5% rate (201 of 3646; adjusted hazard ratio [HR] 0·81, 95% CI 0·77–0·84; p<0·0001), and full lockdowns with a 15·0% rate (1775 of 11 827; HR 0·51, 0·50–0·53; p<0·0001). In sensitivity analyses, including adjustment for SARS-CoV-2 case notification rates, moderate lockdowns (HR 0·84, 95% CI 0·80–0·88; p<0·001), and full lockdowns (0·57, 0·54–0·60; p<0·001), remained independently associated with non-operation. Surgery beyond 12 weeks from diagnosis in patients without neoadjuvant therapy increased during lockdowns (374 [9·1%] of 4521 in light restrictions, 317 [10·4%] of 3646 in moderate lockdowns, 2001 [23·8%] of 11827 in full lockdowns), although there were no differences in resectability rates observed with longer delays. Interpretation Cancer surgery systems worldwide were fragile to lockdowns, with one in seven patients who were in regions with full lockdowns not undergoing planned surgery and experiencing longer preoperative delays. Although short-term oncological outcomes were not compromised in those selected for surgery, delays and non-operations might lead to long-term reductions in survival. During current and future periods of societal restriction, the resilience of elective surgery systems requires strengthening, which might include protected elective surgical pathways and long- term investment in surge capacity for acute care during public health emergencies to protect elective staff and services. Funding National Institute for Health Research Global Health Research Unit, Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, Medtronic, Sarcoma UK, The Urology Foundation, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.
BASE